12:00 AM
 | 
Feb 21, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ADI-PEG 20: Phase II started

Polaris began an open-label, international Phase II trial evaluating weekly 320 IU/m 2 intramuscular ADI-PEG 20 in 4-week cycles in...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >